Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Revolutionizing Heart Failure Management: Nonsteroidal Mineralocorticoid Receptor Antagonists in Focus
